Skip to main content
. 2016 Sep 12;17(9):1500. doi: 10.3390/ijms17091500

Figure 3.

Figure 3

(A) Comparison of WFA+-M2BP level in patients with and without HCC (p = 0.0004); (B) Comparison of WFA+-M2BP level in patients with stage I or II HCC and stage III or IV HCC (p = 0.2554).